ercial products and continued low productivity of pharma R&D. The Fund Managers believe these dynamics offer venture © Food and Drug Administration. Center For Drug Evaluation and Research Dow Jones; Fenwick & West Analysis in 2012 Trends in Terms of Life Science Venture Financings 5 CONTROL NUMBER 257 - CONFIDENTIAL HOUS